Market Overview

Credit Suisse Maintains on Covisint

Share:
Related COVS
11 Emerging Tech Names Pacific Crest Is Watching
UPDATE: Credit Suisse Resumes Coverage On Covisint On Limited Upside
Covisint Corporation: Former Spinoff Trading At Attractive Valuations (Seeking Alpha)

In a report published Friday, Credit Suisse analyst Michael Nemeroff maintained Outperform on Covisint (NASDAQ: COVS), dropping its target price to $17.00 from $18.00.

According to the report, the analyst's $17.00 target price is based on a blended average using 50 percent of their discounted cash flow (DCF) valuation and 50% of their relative comparable multiples to its peers.

“We believe that this target price and multiple are warranted due to our confidence that the company's previously signed ASR gives a high degree of visibility into future revenue growth, that it will continue to diversify its revenue base by successfully expanding its platform into new verticals, and that demand for PaaS in mature markets will increase over the next few years,” the report noted.

COVS closed Thursday at $12.84.

Latest Ratings for COVS

DateFirmActionFromTo
Mar 2015Credit SuisseDowngradesNeutralUnderperform
May 2014Pacific CrestDowngradesOutperformSector Perform
Mar 2014Credit SuisseDowngradesOutperformNeutral

View More Analyst Ratings for COVS
View the Latest Analyst Ratings

Posted-In: Credit Suisse Michael NemeroffAnalyst Color Reiteration Analyst Ratings

 

Related Articles (COVS)

Around the Web, We're Loving...